XSHE
002614
Market cap687mUSD
Dec 05, Last price
7.80CNY
1D
2.63%
1Q
10.80%
Jan 2017
-41.53%
IPO
-19.86%
Name
Xiamen Comfort Science & Technology Group Co Ltd
Chart & Performance
P/E
75.70
P/S
1.01
EPS
0.10
Div Yield, %
3.85%
Shrs. gr., 5y
2.54%
Rev. gr., 5y
-1.74%
Revenues
4.83b
-3.92%
Net income
64m
-37.76%
CFO
130m
-85.45%
Dividend
May 29, 20240.3 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Xiamen Comfort Science&Technology Group Co., Ltd researches, develops, manufactures, and sells health massage appliances in China and internationally. The company provides massage chairs and appliances, humidifier, air purifiers, fresh air systems, blood pressure monitors, oximeters, laser hair removal devices, sports bracelets, other home medical products, etc. It offers its products primarily under the OGAWA, FUJI, FUJIMEDIC, COZZIA, MEDISANA, EASEWELL, ihoco, SHUSIJIA, and ETRO brand names. The company was formerly known as Xiamen Comfort Science&Technology Group Co., Ltd. and changed its name to Ogawa Smart Healthcare Technology Group Co., Ltd. in May 2017. The company was founded in 1996 and is based in Xiamen, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||